Table 3.
Comparison between study populations based on Elabela-21 and Elabela-11 according to sex
| Parameters | Groups | Male (Mean ± SE) |
Female (Mean ± SE) |
P-Value | C.S. |
|---|---|---|---|---|---|
| Elabela-21 (pg/mL) | Control (n=60) | 543.68 ± 5.07 | 541.72 ± 5.18 | 0.7876 | P>0.05 (NS) |
| Prediabetes (n=60) | 638.12 ± 3.76 | 644.36 ± 5.23 | 0.337 | P>0.05 (NS) | |
| T2DM (n=60) | 797.19 ± 14.05 | 809.22 ± 18.58 | 0.6044 | P>0.05 (NS) | |
| Elabela-11 (pg/mL) | Control (n=60) | 139.65 ± 5.16 | 142.01 ± 5.11 | 0.7464 | P>0.05 (NS) |
| Prediabetes (n=60) | 335.88 ± 4.30 | 342.62 ± 5.40 | 0.334 | P>0.05 (NS) | |
| T2DM (n=60) | 494.48 ± 13.51 | 510.86 ± 19.07 | 0.4817 | P>0.05 (NS) |